The global nanotechnology-based medical devices market is expected to grow at a CAGR of 12.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for minimally invasive surgeries and rising prevalence of chronic diseases such as diabetes and cancer.
The global nanotechnology-based medical devices market by type is segmented into biochips, implantable materials, therapeutic devices, diagnostic devices, and research devices. The therapeutic segment accounted for the largest share in 2018 owing to its wide range of applications in various fields such as cardiology, neurology, oncology and orthopedics. The diagnostic segment accounted for the second largest share in 2018 due to its wide range of applications in various fields such as cardiology, neurology oncology and orthopedics.
Nanotechnology-based medical devices are used in the diagnosis and treatment of diseases. The market is driven by the increasing demand for minimally invasive procedures, which require less recovery time and have fewer side effects. Nanotechnology-based medical devices are also used to detect cancerous cells in blood samples, which helps doctors diagnose cancer earlier.
Industry Growth Insights published a new data on “Nanotechnology-based Medical Devices Market”. The research report is titled “Nanotechnology-based Medical Devices Market research by Types (Biochips, Implantable Materials, Other), By Applications (Therapeutic, Diagnostic, Research), By Players/Companies 3M, Dentsply International, Mitsui Chemicals, Stryker, AAP Implantate, Affymetrix, Perkinelmer, Abbott, Smith & Nephew, Starkey Hearing Technologies”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Nanotechnology-based Medical Devices Market Research Report
By Type
Biochips, Implantable Materials, Other
By Application
Therapeutic, Diagnostic, Research
By Companies
3M, Dentsply International, Mitsui Chemicals, Stryker, AAP Implantate, Affymetrix, Perkinelmer, Abbott, Smith & Nephew, Starkey Hearing Technologies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Nanotechnology-based Medical Devices Market Report Segments:
The global Nanotechnology-based Medical Devices market is segmented on the basis of:
Types
Biochips, Implantable Materials, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Therapeutic, Diagnostic, Research
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 3M
- Dentsply International
- Mitsui Chemicals
- Stryker
- AAP Implantate
- Affymetrix
- Perkinelmer
- Abbott
- Smith & Nephew
- Starkey Hearing Technologies
Highlights of The Nanotechnology-based Medical Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Biochips
- Implantable Materials
- Other
- By Application:
- Therapeutic
- Diagnostic
- Research
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nanotechnology-based Medical Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nanotechnology-based medical devices are those that use nanotechnology to create or improve the functionality of medical devices. Nanotechnology can be used to create smaller, more effective medical devices, as well as help prevent the spread of disease.
Some of the key players operating in the nanotechnology-based medical devices market are 3M, Dentsply International, Mitsui Chemicals, Stryker, AAP Implantate, Affymetrix, Perkinelmer, Abbott, Smith & Nephew, Starkey Hearing Technologies.
The nanotechnology-based medical devices market is expected to grow at a compound annual growth rate of 12.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nanotechnology-based Medical Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Nanotechnology-based Medical Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Nanotechnology-based Medical Devices Market - Supply Chain
4.5. Global Nanotechnology-based Medical Devices Market Forecast
4.5.1. Nanotechnology-based Medical Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Nanotechnology-based Medical Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Nanotechnology-based Medical Devices Market Absolute $ Opportunity
5. Global Nanotechnology-based Medical Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Nanotechnology-based Medical Devices Market Size and Volume Forecast by Type
5.3.1. Biochips
5.3.2. Implantable Materials
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Nanotechnology-based Medical Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Nanotechnology-based Medical Devices Market Size and Volume Forecast by Application
6.3.1. Therapeutic
6.3.2. Diagnostic
6.3.3. Research
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Nanotechnology-based Medical Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Nanotechnology-based Medical Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Nanotechnology-based Medical Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Nanotechnology-based Medical Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Nanotechnology-based Medical Devices Demand Share Forecast, 2019-2026
9. North America Nanotechnology-based Medical Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Nanotechnology-based Medical Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Nanotechnology-based Medical Devices Market Size and Volume Forecast by Application
9.4.1. Therapeutic
9.4.2. Diagnostic
9.4.3. Research
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Nanotechnology-based Medical Devices Market Size and Volume Forecast by Type
9.7.1. Biochips
9.7.2. Implantable Materials
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Nanotechnology-based Medical Devices Demand Share Forecast, 2019-2026
10. Latin America Nanotechnology-based Medical Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Nanotechnology-based Medical Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Nanotechnology-based Medical Devices Market Size and Volume Forecast by Application
10.4.1. Therapeutic
10.4.2. Diagnostic
10.4.3. Research
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Nanotechnology-based Medical Devices Market Size and Volume Forecast by Type
10.7.1. Biochips
10.7.2. Implantable Materials
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Nanotechnology-based Medical Devices Demand Share Forecast, 2019-2026
11. Europe Nanotechnology-based Medical Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Nanotechnology-based Medical Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Nanotechnology-based Medical Devices Market Size and Volume Forecast by Application
11.4.1. Therapeutic
11.4.2. Diagnostic
11.4.3. Research
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Nanotechnology-based Medical Devices Market Size and Volume Forecast by Type
11.7.1. Biochips
11.7.2. Implantable Materials
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Nanotechnology-based Medical Devices Demand Share, 2019-2026
12. Asia Pacific Nanotechnology-based Medical Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Nanotechnology-based Medical Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Nanotechnology-based Medical Devices Market Size and Volume Forecast by Application
12.4.1. Therapeutic
12.4.2. Diagnostic
12.4.3. Research
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Nanotechnology-based Medical Devices Market Size and Volume Forecast by Type
12.7.1. Biochips
12.7.2. Implantable Materials
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Nanotechnology-based Medical Devices Demand Share, 2019-2026
13. Middle East & Africa Nanotechnology-based Medical Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Nanotechnology-based Medical Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Nanotechnology-based Medical Devices Market Size and Volume Forecast by Application
13.4.1. Therapeutic
13.4.2. Diagnostic
13.4.3. Research
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Nanotechnology-based Medical Devices Market Size and Volume Forecast by Type
13.7.1. Biochips
13.7.2. Implantable Materials
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Nanotechnology-based Medical Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Nanotechnology-based Medical Devices Market: Market Share Analysis
14.2. Nanotechnology-based Medical Devices Distributors and Customers
14.3. Nanotechnology-based Medical Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. 3M
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Dentsply International
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Mitsui Chemicals
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Stryker
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. AAP Implantate
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Affymetrix
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Perkinelmer
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Abbott
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Smith & Nephew
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Starkey Hearing Technologies
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
